MED12 and acute lymphoblastic leukemia: While further investigations are required to fully decipher the mechanisms underlying the observed USP9X and MED12 induced anti-apoptotic effects, the identification of two novel X-linked tumor suppressor genes in pediatric T-ALL and their co-occurrence with known X-linked driver gene mutations (PHF6) suggests cooperating effects of X-linked mutations in T-ALL onset.